- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Allergan Inc/United States
+ Add to WatchlistAGN:US
98.0200 USD 0.0600 0.06%
Share
As of 20:04:03 ET on 05/24/2013.
More on AGN
News for Allergan Inc/United States (AGN)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Obesity Surgery in India Spurs J&J Stomach-Staple Sales
- Governor Christie Had Weight Loss Surgery in February
- U.S. Stock Options With Biggest Changes in Implied Volatility
- S&P 500 Stocks Biggest Weekly Changes in Target Price
- Maker of Botox Plunges the Most in 13 Years
- Allergan Shares Fall After CEO Says Two Studies Delayed
- Allergan Shares Fall After CEO Says Drug Trial Will Be Delayed
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Solvency II Rules Seen as Costing U.K. Insurers $310 Million
- Cosmetic Procedures Need Tighter Restrictions: U.K. Panel
- Dutch Mortgage-Bond Market Threatened by Capital Rules, DSA Says
- Chili Peppers Seen Helping 36 Million Migraine Sufferers
- Allergan’s Migraine Drug Inhaler Levadex Rejected
- Allergan Investor Claims Over Botox Penalty Thrown Out
- EIOPA Begins Discussions on Insurers’ Interim Solvency Rules
- Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer Published May 23, 2013
- IRSH: Elan Corporation PLC: Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Published May 23, 2013
- ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Published May 20, 2013
- ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index Published May 20, 2013
- ACADIA Pharmaceuticals Prices Public Offering of Common Stock Published May 15, 2013
- ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Published May 14, 2013
- KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results Published May 13, 2013
- True Results Reports That Only 1 in 21 Medically-Eligible People Are Likely to Consider Weight-Loss Surgery, Such as LAP-BAND, Published May 10, 2013
- ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results Published May 07, 2013
- FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Published May 02, 2013
- Allergan Reports First Quarter 2013 Operating Results Published May 01, 2013
- Tau Founder Dr. Timothy L. Macdonald Honored for Contributions to Virginia Bioscience Published May 01, 2013
- ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013 Published Apr 30, 2013
- Allergan Announces Death of Stephen J. Ryan, M.D. Published Apr 30, 2013
- FDA STAFF REVIEW OF ALLERGAN'S JUVEDERM VOLUMA XC Published Apr 30, 2013
- Valeant Said to Be Near to Acquiring Bausch & Lomb
- Warburg Would Get Threefold Return in Bausch Transaction
- Siga Ruled Liable for Breaking PharmAthene Drug Contract
- Bausch & Lomb Unit Pays $33.5 Million in Misbranding Case
- Canadian Stocks Rise as Valeant Jump Offsets Slumps in Oil, Gold
- Winteam to Buy Tongjitang Medicine for $393 Million
- Mathew Martoma Will Get Documents From SEC, Judge Says
- Swiss Stocks Little Changed, After 2.8% Decline Yesterday
- European Stocks Fall for Second Day Amid Stimulus Debate
- U.K. Stocks Drop for Second Day as Investors Consider Fed
- Wockhardt Drug Filings Seen Delayed After U.S. FDA Alert
- Apple’s Tax Magic Leaves Irish Bondholders Unmoved: Euro Credit
- Murray International’s Stout Says Stocks Too Expensive
- Elan Board Unanimously Rejects $6.4B Takeover Offer
- Wockhardt Has Biggest 2-Day Drop on Record on U.S. Restrictions
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page